Ashleigh R. Poh

Richmond, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Progress and challenges in expanding access to clinical trials in pancreatic cancer.

Progress and challenges in expanding access to clinical trials in pancreatic cancer.

Journal: Communications medicine
Published: June 01, 2026

Circulating inflammatory ILC2s as a biomarker of gastric cancer progression.

Circulating inflammatory ILC2s as a biomarker of gastric cancer progression.

Journal: bioRxiv : the preprint server for biology
Published: May 07, 2026

Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations.

Progress, challenges, and future directions of pancreatic cancer surveillance in high-risk populations.

Journal: Communications medicine
Published: April 14, 2026

The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity.

The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity.

Journal: Frontiers in immunology
Published: September 19, 2025

Correction: Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.

Correction: Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer.

Journal: Cell death & disease
Published: May 12, 2025

Lung cancer biobanking in Australia: challenges and future directions.

Lung cancer biobanking in Australia: challenges and future directions.

Journal: The Medical journal of Australia
Published: January 16, 2025

A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic adenocarcinoma.

A retrospective analysis of Selective Internal Radiation Therapy (SIRT) and chemotherapy for metastatic pancreatic adenocarcinoma.

Journal: BMC cancer
Published: November 06, 2024

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines.

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines.

Journal: Cell reports
Published: February 01, 2024

Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies.

Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies.

Journal: Trends in immunology
Published: October 04, 2023

Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3.

Mechanisms of cellular crosstalk in the gastric tumor microenvironment are mediated by YAP1 and STAT3.

Journal: Life science alliance
Published: October 02, 2023

Editorial: Overcoming drug relapse and therapy resistance in NSCLC.

Editorial: Overcoming drug relapse and therapy resistance in NSCLC.

Journal: Frontiers in oncology
Published: May 29, 2023

Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.

Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities.

Journal: Oncogene
Published: February 19, 2023
Showing 1-12 of 39

Last Updated: 09/26/2026